NCT06128629Phase 3Recruiting

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-12Estimated

Enrollment · participants1200Estimated

Source updated2026-03-27Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-03-27 · 1 field changed

Recruitment status changed

− Before

~~Active not recruiting~~

+ After

Recruiting

Check registry source

Posted 2025-12-02 · 2 fields changed

Planned enrollment increased by 435 participants

− Before

~~765 participants (planned)~~

+ After

1200 participants (planned)

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source